Cited 5 times in
A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.